---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-101984"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2025-10-24T23:59:59+00:00"
generated_at: "2026-05-17T02:23:50.887636+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Acura borrows additional $300k from AD Pharma; warns of potential bankruptcy by early Nov 2025

## Summary
- Principal balance on amended secured note reaches $8,994,279, with ~$865k accrued interest at 5.25%.
- Three new $100k loans from AD Pharma (Sept 12, Oct 6, Oct 23 2025) used for day-to-day operations.
- Without additional financing by early November 2025, company will need to scale back, furlough or terminate operations.
- AD Pharma, which owns ~65% of Acura's common stock, is controlled by Mr. Schutte.
- Interest rate on overdue amounts jumps to 7.5% per annum upon default.

## SEC filing metadata
- accession: 0001104659-25-101984
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2025-10-24T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/0001104659-25-101984-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/tm2529376d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-101984
- JSON: https://secwatch.observer/filing/0001104659-25-101984.json
- Plain text: https://secwatch.observer/filing/0001104659-25-101984.txt

## Key facts
- Debt Financings
  ACURA PHARMACEUTICALS, INC incurred loan of $100,000 with Abuse Deterrent Pharma, LLC at 5.25%.
  - Instrument: loan
  - Principal: $100,000
  - Counterparty: Abuse Deterrent Pharma, LLC
  - Rate: 5.25%
  - Event: incurrence
  source text: On each of September 12, 2025, October 6, 2025 and October 23, 2025 we received loans of $100,000 from Abuse Deterrent Pharma, LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/0001104659-25-101984-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.